Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists
Oncotarget · 2024
DOI: 10.18632/oncotarget.28672 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncotarget, 2024. Verfasst von Theia Minev und 5 weiteren Autor:innen. Beteiligte Einrichtung: CureScience Institute, San Diego, CA 92121, USA. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Neoplasms, Tumor Microenvironment, Mesenchymal Stem Cell Transplantation. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are recognized for their immunomodulatory capabilities, tumor-homing abilities, and capacity to serve as carriers for therapeutic agents. This review delves into the role of adoptively transferred MSCs in tumor progression, their interactions with the tumor microenvironment, and their use in delivering anti-cancer drugs, oncolytic viruses, and genetic material. It also addresses the challenges and limitations associated with MSC therapy, such as variability in MSC preparations and potential tumorigenic effects emphasizing the need for advanced genetic engineering and personalized approaches to enhance therapeutic efficacy. The review concludes with an optimistic outlook on the future of MSC-based therapies, underscoring their promise to develop effective and personalized cancer treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CureScience Institute, San Diego, CA 92121, USA.
- Sonata Therapeutics, Boston, MA 02472, USA.
- Department of Translational Neurosciences, Pacific Neuroscience Institute and Providence Saint John's Health Center, Saint John's Cancer Institute, Santa Monica, CA 90404, USA.
Zitieren
APA
Minev, T., Balbuena, S., Gill, J. M., Marincola, F. M., Kesari, S., & Lin, F. (2024). Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget. https://doi.org/10.18632/oncotarget.28672
Vancouver
Minev T, Balbuena S, Gill JM, Marincola FM, Kesari S, Lin F. Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget. 2024. doi:10.18632/oncotarget.28672
BibTeX
@article{Minev2024,
author = {Minev, Theia and Balbuena, Shani and Gill, Jaya Mini and Marincola, Francesco M and Kesari, Santosh and Lin, Feng},
title = {Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists},
journal = {Oncotarget},
year = {2024},
doi = {10.18632/oncotarget.28672}
}
EUVIMED